Scancell Holdings PLC

LSE:SCLP (UK)  
£ 0.10 (0%) Mar 28
At Loss
Market Cap:
£ 95.10M ($ 120.05M)
Enterprise V:
£ 101.84M ($ 128.55M)
Volume:
239.64K
Avg Vol (2M):
308.56K
Also Trade In:
Volume:
239.64K
At Loss
Avg Vol (2M):
308.56K

Business Description

Description
Scancell Holdings PLC is engaged in the discovery and development of novel vaccines for the treatment of cancer. The company is exploiting the unrivalled potential of the immune system to seek out and destroy cancer using two proprietary immuno-oncology platforms: ImmunoBody and Moditope. Its potent innovative DNA-based ImmunoBody therapies generate ultra-high avidity T cell responses that target and eliminate cancerous tumors. Its Moditope platform technology overcomes the immune suppression induced by tumors themselves, allowing activated T cells to seek out and kill tumor cells that would otherwise be hidden from the immune system.
Name Current Vs Industry Vs History
Cash-To-Debt 0.66
Equity-to-Asset -0.38
Debt-to-Equity -2.37
Debt-to-EBITDA -1.99
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -2.28
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -2.3
3-Year EPS without NRI Growth Rate -5.3
Name Current Vs Industry Vs History
5-Day RSI 33.64
9-Day RSI 37.57
14-Day RSI 39.57
6-1 Month Momentum % -37.29
12-1 Month Momentum % -32.77

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.63
Quick Ratio 8.63
Cash Ratio 6.64
Days Sales Outstanding 41.03
Days Payable 652.83

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -18.2
Shareholder Yield % -5.74
Name Current Vs Industry Vs History
Gross Margin % 90.04
Operating Margin % -226.14
Net Margin % -226.45
FCF Margin % -201.18
ROE % -3448.01
ROA % -31.43
ROIC % -153.06
ROC (Joel Greenblatt) % -196.51
ROCE % -39.16

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 17.08
EV-to-EBIT -9.42
EV-to-EBITDA -10.25
EV-to-Forward-EBITDA -7.57
EV-to-Revenue 19.32
EV-to-FCF -9.6
Earnings Yield (Greenblatt) % -10.62
FCF Yield % -11.15

Financials (Next Earnings Date:2024-10-24 Est.)

LSE:SCLP's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Scancell Holdings PLC Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil £) 5.271
EPS (TTM) (£) -0.012
Beta 1.42
Volatility % 86.31
14-Day RSI 39.57
14-Day ATR (£) 0.00766
20-Day SMA (£) 0.104788
12-1 Month Momentum % -32.77
52-Week Range (£) 0.07585 - 0.209918
Shares Outstanding (Mil) 927.82

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Scancell Holdings PLC Filings

Filing Date Document Date Form
No Filing Data

Scancell Holdings PLC Stock Events

Financials Calendars
Event Date Price(£)
No Event Data

Scancell Holdings PLC Frequently Asked Questions

What is Scancell Holdings PLC(LSE:SCLP)'s stock price today?
The current price of LSE:SCLP is £0.10. The 52 week high of LSE:SCLP is £0.21 and 52 week low is £0.08.
When is next earnings date of Scancell Holdings PLC(LSE:SCLP)?
The next earnings date of Scancell Holdings PLC(LSE:SCLP) is 2024-10-24 Est..
Does Scancell Holdings PLC(LSE:SCLP) pay dividends? If so, how much?
Scancell Holdings PLC(LSE:SCLP) does not pay dividend.

Press Release

Subject Date
No Press Release